Connecticut 2011 Regular Session

Connecticut Senate Bill SB00915

Introduced
2/7/11  
Introduced
2/7/11  
Refer
2/7/11  
Refer
2/7/11  
Report Pass
3/3/11  
Refer
3/7/11  
Report Pass
3/9/11  
Report Pass
3/9/11  
Refer
3/16/11  

Caption

An Act Concerning The Chemical Innovations Institute At The University Of Connecticut And The Prohibition On Bisphenol-a In Infant Formula And Baby Food Containers, Jars And Cans.

Impact

The enactment of SB 00915 will necessitate changes in manufacturing practices related to infant food and promote safer alternatives to BPA in food packaging. By formally banning BPA, the bill aims to enhance public health protections, particularly for vulnerable populations such as infants. The law would thus align Connecticut with an increasing number of states seeking to regulate chemicals in consumer products, reflecting a growing public demand for safer food packaging practices and transparency in manufacturing processes.

Summary

Senate Bill 00915 addresses health and safety concerns regarding the presence of Bisphenol-A (BPA) in infant formula and baby food containers. The bill proposes to prohibit the manufacture and sale of infant formula and baby food stored in containers that contain BPA, effective from October 1, 2011. The intent is to protect infants and young children from potential exposure to harmful chemicals in food packaging. Additionally, the bill establishes the Chemical Innovations Institute at the University of Connecticut to oversee related research and provide recommendations on chemical policy, focusing on sustainable practices in manufacturing.

Sentiment

Overall, the sentiment around SB 00915 is largely positive among health advocates and environmental groups who support the initiative to safeguard children's health. They view the bill as a proactive measure to reduce potential health risks associated with BPA exposure. However, there may be some concerns from manufacturers about the implications of the ban on their existing inventory and the need to revise production methods swiftly, potentially leading to increased costs or operational challenges.

Contention

A notable point of contention surrounding SB 00915 could revolve around the balance between health safety and economic impact. While proponents of the bill argue that prioritizing children's health is paramount, manufacturers might argue that such regulations could lead to increased costs in terms of both production and consumer prices. Another aspect of debate could focus on the enforcement mechanisms and the timeline allowed for businesses to adapt to the new regulations concerning existing inventory of infant formula and baby food containers containing BPA.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.